Ruboxistaurin, a Protein Kinase C {beta} Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of pharmacotherapy 2005-10, Vol.39 (10), p.1693
Hauptverfasser: Joy, Scott V, Scates, Ann C, Bearelly, Srilaxmi, Dar, Moahad, Taulien, Christina A, Goebel, Jason A, Cooney, Michael J
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 10
container_start_page 1693
container_title The Annals of pharmacotherapy
container_volume 39
creator Joy, Scott V
Scates, Ann C
Bearelly, Srilaxmi
Dar, Moahad
Taulien, Christina A
Goebel, Jason A
Cooney, Michael J
description
doi_str_mv 10.1345/aph.1E572
format Article
fullrecord <record><control><sourceid>highwire</sourceid><recordid>TN_cdi_highwire_smallpub1_www39_10_1693</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>www39_10_1693</sourcerecordid><originalsourceid>FETCH-highwire_smallpub1_www39_10_16933</originalsourceid><addsrcrecordid>eNqNi81KxDAURoMozviz8A3uzo0dk3SasevaQRFBZPbltmTaK2lS8mMF8d3twgdw9Z0D52PsRvCNyLfFPU7DRtTFTp6wtSi2MlNyx08X5opnXD7wFbsI4YNzXgpZnrOVUEItJtcsvafWfVGImDzZO0B48y5qsvBCFoOGCr5bHfEHnu1ALUXnlygAWqhH7XuyPRy8xjhqG-HoPDwSLgcd4JU67z4xdMmgh8qNk6EOIzkbrtjZEU3Q1397yW739aF6ygbqh5m8bsKIxkypFc08z3nZCN4IVeb5_8tfKF5W7Q</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Ruboxistaurin, a Protein Kinase C {beta} Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications</title><source>SAGE Complete A-Z List</source><creator>Joy, Scott V ; Scates, Ann C ; Bearelly, Srilaxmi ; Dar, Moahad ; Taulien, Christina A ; Goebel, Jason A ; Cooney, Michael J</creator><creatorcontrib>Joy, Scott V ; Scates, Ann C ; Bearelly, Srilaxmi ; Dar, Moahad ; Taulien, Christina A ; Goebel, Jason A ; Cooney, Michael J</creatorcontrib><identifier>ISSN: 1060-0280</identifier><identifier>EISSN: 1542-6270</identifier><identifier>DOI: 10.1345/aph.1E572</identifier><identifier>PMID: 16160002</identifier><language>eng</language><publisher>Harvey Whitney Books</publisher><ispartof>The Annals of pharmacotherapy, 2005-10, Vol.39 (10), p.1693</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Joy, Scott V</creatorcontrib><creatorcontrib>Scates, Ann C</creatorcontrib><creatorcontrib>Bearelly, Srilaxmi</creatorcontrib><creatorcontrib>Dar, Moahad</creatorcontrib><creatorcontrib>Taulien, Christina A</creatorcontrib><creatorcontrib>Goebel, Jason A</creatorcontrib><creatorcontrib>Cooney, Michael J</creatorcontrib><title>Ruboxistaurin, a Protein Kinase C {beta} Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications</title><title>The Annals of pharmacotherapy</title><issn>1060-0280</issn><issn>1542-6270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqNi81KxDAURoMozviz8A3uzo0dk3SasevaQRFBZPbltmTaK2lS8mMF8d3twgdw9Z0D52PsRvCNyLfFPU7DRtTFTp6wtSi2MlNyx08X5opnXD7wFbsI4YNzXgpZnrOVUEItJtcsvafWfVGImDzZO0B48y5qsvBCFoOGCr5bHfEHnu1ALUXnlygAWqhH7XuyPRy8xjhqG-HoPDwSLgcd4JU67z4xdMmgh8qNk6EOIzkbrtjZEU3Q1397yW739aF6ygbqh5m8bsKIxkypFc08z3nZCN4IVeb5_8tfKF5W7Q</recordid><startdate>20051001</startdate><enddate>20051001</enddate><creator>Joy, Scott V</creator><creator>Scates, Ann C</creator><creator>Bearelly, Srilaxmi</creator><creator>Dar, Moahad</creator><creator>Taulien, Christina A</creator><creator>Goebel, Jason A</creator><creator>Cooney, Michael J</creator><general>Harvey Whitney Books</general><scope/></search><sort><creationdate>20051001</creationdate><title>Ruboxistaurin, a Protein Kinase C {beta} Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications</title><author>Joy, Scott V ; Scates, Ann C ; Bearelly, Srilaxmi ; Dar, Moahad ; Taulien, Christina A ; Goebel, Jason A ; Cooney, Michael J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-highwire_smallpub1_www39_10_16933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Joy, Scott V</creatorcontrib><creatorcontrib>Scates, Ann C</creatorcontrib><creatorcontrib>Bearelly, Srilaxmi</creatorcontrib><creatorcontrib>Dar, Moahad</creatorcontrib><creatorcontrib>Taulien, Christina A</creatorcontrib><creatorcontrib>Goebel, Jason A</creatorcontrib><creatorcontrib>Cooney, Michael J</creatorcontrib><jtitle>The Annals of pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Joy, Scott V</au><au>Scates, Ann C</au><au>Bearelly, Srilaxmi</au><au>Dar, Moahad</au><au>Taulien, Christina A</au><au>Goebel, Jason A</au><au>Cooney, Michael J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ruboxistaurin, a Protein Kinase C {beta} Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications</atitle><jtitle>The Annals of pharmacotherapy</jtitle><date>2005-10-01</date><risdate>2005</risdate><volume>39</volume><issue>10</issue><spage>1693</spage><pages>1693-</pages><issn>1060-0280</issn><eissn>1542-6270</eissn><pub>Harvey Whitney Books</pub><pmid>16160002</pmid><doi>10.1345/aph.1E572</doi></addata></record>
fulltext fulltext
identifier ISSN: 1060-0280
ispartof The Annals of pharmacotherapy, 2005-10, Vol.39 (10), p.1693
issn 1060-0280
1542-6270
language eng
recordid cdi_highwire_smallpub1_www39_10_1693
source SAGE Complete A-Z List
title Ruboxistaurin, a Protein Kinase C {beta} Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T20%3A35%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-highwire&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ruboxistaurin,%20a%20Protein%20Kinase%20C%20%7Bbeta%7D%20Inhibitor,%20as%20an%20Emerging%20Treatment%20for%20Diabetes%20Microvascular%20Complications&rft.jtitle=The%20Annals%20of%20pharmacotherapy&rft.au=Joy,%20Scott%20V&rft.date=2005-10-01&rft.volume=39&rft.issue=10&rft.spage=1693&rft.pages=1693-&rft.issn=1060-0280&rft.eissn=1542-6270&rft_id=info:doi/10.1345/aph.1E572&rft_dat=%3Chighwire%3Ewww39_10_1693%3C/highwire%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16160002&rfr_iscdi=true